GlassScriptPhysician profile
Cesar Hurtado
NPI 1649632886
$2,261.96
in general payments reported to CMS, 2019-2025
11 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $125 · 2021: $265 · 2022: $125 · 2023: $603 · 2024: $334 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $692.58 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $353.70 | 2021-2024 | |
| Gilead Sciences, INC. | $237.61 | 2019-2023 | Epclusa |
| Astrazeneca Pharmaceuticals LP | $212.65 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Abbott Laboratories | $170.70 | 2019-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $150.93 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Genentech USA, INC. | $139.41 | 2020-2021 | |
| Amgen INC. | $124.99 | 2019 | |
| Lilly USA, LLC | $106.62 | 2023-2024 | Mounjaro, Zepbound, Trulicity |
| Dexcom, INC. | $47.57 | 2025 | Dexcom G6 Transmitter |
| Pulpdent Corporation | $25.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Hurtado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.